Weiwei Lu

Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial

Yan Liu, X. Guan, Y. Tong, 2022, EClinicalMedicine.

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial

F. Zhu, Xiuling Li, Kai Duan, 2022, Human vaccines & immunotherapeutics.